8-K: Teladoc Health CLO Resigns, Transition Plan in Place
Current Report (Form 8-K)
Teladoc Health, Inc. announced the resignation of its Chief Legal Officer and Secretary, Adam C. Vandervoort, effective November 1, 2026, with a transition to Jonathan Dorfman.
Summary
- Adam C. Vandervoort, Chief Legal Officer and Secretary of Teladoc Health, Inc., has resigned, with his departure effective November 1, 2026.
- Mr. Vandervoort's resignation is considered to be for good reason under his executive severance agreement.
- He will provide advisory services to support the transition of his duties until November 1, 2027, without additional compensation.
- Jonathan Dorfman, currently Senior Vice President, Securities & Corporate Law, will assume the role of Chief Legal Officer and Secretary.
- The company expressed gratitude to Mr. Vandervoort for his service.
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a neutral to slightly negative development due to a key executive departure, though the transition plan appears orderly.
Positives
- An orderly transition plan is in place for the Chief Legal Officer role.
- Mr. Vandervoort will provide advisory services to ensure a smooth handover.
- The company thanked Mr. Vandervoort for his service, indicating a professional separation.
Negatives
- Departure of a key executive (Chief Legal Officer and Secretary).
- The resignation may indicate underlying issues or a desire for new leadership direction.
Risks
- Potential disruption during the transition period if not managed effectively.
- Loss of institutional knowledge held by the departing Chief Legal Officer.
- Uncertainty regarding the long-term strategic direction of the legal department under new leadership.
Future Outlook
The filing does not contain forward-looking financial statements or guidance. The outlook pertains to the internal transition of executive responsibilities.
Management Comments
- The Company thanks Mr. Vandervoort for his years of service.
Industry Context
StockSavvy.ai notes that executive turnover, particularly in legal and compliance roles, can sometimes signal shifts in strategy or internal challenges within the telehealth and virtual care industry, which is highly regulated.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Legal Officer and Secretary | Adam C. Vandervoort | Jonathan Dorfman | 2026-11-01 | Resignation of Adam C. Vandervoort |
Stakeholder Impact
- Shareholders: Potential for short-term uncertainty regarding leadership stability, but the orderly transition may mitigate significant impact.
- Employees: May experience a period of adjustment to new legal leadership.
- Creditors: No immediate impact indicated, as the filing focuses on executive changes.
Next Steps
- Jonathan Dorfman to assume the role of Chief Legal Officer and Secretary.
- Mr. Vandervoort to provide advisory services for transition support until November 1, 2027.
Key Dates
| Date | Description |
|---|---|
| 2025-10-17 | Former Address Date |
| 2026-09-24 | Date of Report (Earliest event reported) |
| 2026-11-01 | Effective date of Mr. Vandervoort's resignation |
| 2027-11-01 | End date for Mr. Vandervoort's advisory services |
| 2026-09-25 | Date of signature on the report |
Keywords
Chief Legal Officer resignation, Corporate Secretary departure, Executive transition, Legal leadership change, Teladoc Health management
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.